Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 9:17:12 PM : Outperform Start Price: $41.69 COV Score: +20.12

12/13

Featured Broker Partners


Advertisement